| Old Articles: <Older 22211-22220 Newer> |
|---|
 |
Pharmaceutical Executive
April 1, 2007 |
Deals: No IPO for Organon Akzo Nobel's plans to spin off its Organon Biosciences unit... Oxford BioMedica will acquire the privately held Oxxon Therapeutics... Jazz Pharmaceuticals has filed a registration statement with the SEC for... etc.   |
BusinessWeek
April 23, 2007
Gene G. Marcial |
SunPower Shines Bright Sunpower has captivated investors seeking clean-energy plays, causing the stock to double. |
BusinessWeek
April 23, 2007
Gene G. Marcial |
Avalon's New Lab Partner: Merck Avalon pharmaceuticals, a little-known biopharma focusing on small-molecule therapeutics for cancer, has teamed up with Big Pharma, including Merck, for the use of its AvalonRx drug discovery system. |
BusinessWeek
April 23, 2007
Gene G. Marcial |
Tougher Pollution Rules Are Buoying ADA-ES Control of carbon emissions from coal-fired power plants has long been a hot topic, but states are now slapping limits on mercury output, too. And investors are watching. |
The Motley Fool
April 12, 2007
Emil Lee |
Two Cheap Small-Cap Financial Stocks Put these stocks on your radar screen. Kingsway Financial... CVB Financial... |
The Motley Fool
April 12, 2007
Rich Duprey |
Goodyear: Management 3, Reform 0 Unions' and shareholders' proposals get torpedoed at the tiremaker's annual meeting. Investors, take note. |
The Motley Fool
April 12, 2007
Jack Uldrich |
Nanophase Picks Up the Pace The nanotech company looks to build off a record quarter. Could the stock be poised to gradually increase? |
The Motley Fool
April 12, 2007
Nathan Parmelee |
Posco: Strong as Steel The Korean steelmaker reports stunning financial results, and it sees another strong quarter on the way. |
The Motley Fool
April 12, 2007
Dave Mock |
VimpelCom Is No Wimp The Russian cellular service provider reported fourth-quarter and year-end results that show the same powerful performance that has more than doubled its share price in the past year. |
The Motley Fool
April 12, 2007
Ryan Fuhrmann |
Rite Aid Ekes Out a Gain: Fool by Numbers The drugstore retailer released fourth-quarter and year-end 2007 results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
| <Older 22211-22220 Newer> Return to current articles. |
